brimonidine has been researched along with apraclonidine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Butler, RC; Chapleo, CB; England, DC; Myers, PL; Roach, AG; Smith, CF; Stillings, MR; Tulloch, IF | 1 |
| Counsell, RE; Neubig, R; Van Dort, M | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
3 other study(ies) available for brimonidine and apraclonidine
| Article | Year |
|---|---|
Heteroaromatic analogues of the alpha 2-adrenoreceptor partial agonist clonidine.
Topics: Adrenergic alpha-Agonists; Animals; Brain; Clonidine; Heterocyclic Compounds; Male; Rats; Vas Deferens | 1989 |
Radioiodinated p-iodoclonidine: a high-affinity probe for the alpha 2-adrenergic receptor.
Topics: Affinity Labels; Clonidine; Humans; Iodine Radioisotopes; Receptors, Adrenergic, alpha | 1987 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |